Overview
Matthias Troeltzsch practices in Ansbach, Germany. Mr. Troeltzsch is rated as an Advanced expert by MediFind in the treatment of Maxillary Double Lip. His top areas of expertise are Maxillary Double Lip, Osteonecrosis, Oral Squamous Cell Carcinoma, Pharyngomaxillary Space Abscess, and Osteotomy.
His clinical research consists of co-authoring 66 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Maxillary Double Lip.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Maxillary Double LipMr. Troeltzsch isAdvanced. Learn about Maxillary Double Lip.
- Oral Squamous Cell CarcinomaMr. Troeltzsch isAdvanced. Learn about Oral Squamous Cell Carcinoma.
- OsteonecrosisMr. Troeltzsch isAdvanced. Learn about Osteonecrosis.
- OsteotomyMr. Troeltzsch isAdvanced. Learn about Osteotomy.
- Experienced
- Aphthous StomatitisMr. Troeltzsch isExperienced. Learn about Aphthous Stomatitis.
- Canker SoreMr. Troeltzsch isExperienced. Learn about Canker Sore.
- DiskitisMr. Troeltzsch isExperienced. Learn about Diskitis.
- Head and Neck Squamous Cell Carcinoma (HNSCC)Mr. Troeltzsch isExperienced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Lichen PlanusMr. Troeltzsch isExperienced. Learn about Lichen Planus.
- Oral CancerMr. Troeltzsch isExperienced. Learn about Oral Cancer.